Vaccitech Reports Second Quarter 2023 Financial Results and

OXFORD, United Kingdom, Aug. 10, 2023 -- Vaccitech plc , a clinical-stage biopharmaceutical company engaged in the discovery and development of novel T cell immunotherapeutics designed to harness...
-Today at 08:02 am- MarketScreener

Related Keywords

United Kingdom , United States , Germantown , Maryland , American , Kevin Gardner , Audra Friis , Margaret Marshall , Jonothan Blackbourn , Christopherm Calabrese , Ifng Elispot , Astrazeneca , University Of Oxford , Sam Brown Inc , Oxford University Innovation , International Papillomavirus Conference , Exchange Commission , International Liver Congress , Nasdaq , Cancer Research United Kingdom , Bill Enright , Chief Executive , Recent Corporate , Annual International Papillomavirus Conference , Chief Medical Officer , Investigational New Drug , American Depositary Shares , Cancer Research United , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Markets ,